Epilepsy affects about 50 million people worldwide, making it one of the most common neurological disorders. In India, nearly ...

Objectives: To determine whether patients with psychogenic non-epileptic seizures (PNES) have evidence of maladaptive personality, and whether they have a single or several different typical ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Three-year data from NeuroPace’s Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentationMOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- ...

B was first diagnosed with Lennox-Gastaut syndrome (LGS) due to the frequency and severity of his seizures. He was later ...

Tesla (T) magnetic resonance imaging changes management in more than half of adult candidates for epilepsy surgery.

Joshua “YourRAGE” received a call from his veterinarian during a livestream on April 4, 2025. The doctor said the streamer’s ...

Teddy and Owen took very different approaches to their open marriage, which left major questions about the future of their ...

H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition to new analyses from clinical trials and real ...

CannEpil, a cannabinoid-based therapy for refractory epilepsy, has been approved for prescription in Germany under a special ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...